{
    "Trade/Device Name(s)": [
        "Smartest Persona Blood Glucose Monitoring System"
    ],
    "Submitter Information": "Biotest Medical Corporation",
    "510(k) Number": "K100701",
    "Predicate Device Reference 510(k) Number(s)": [
        "K091815"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW",
        "CGA"
    ],
    "Summary Letter Date": "March 10, 2010",
    "Summary Letter Received Date": "March 12, 2010",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Fresh capillary whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Smartest Persona Blood Glucose Meter"
    ],
    "Method(s)/Technology(ies)": [
        "Glucose oxidase enzymatic method"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "System",
        "Analyzer",
        "Test Strip",
        "Control Solution",
        "Lancing Device"
    ],
    "Document Summary": "FDA 510(k) summary for Smartest Persona Blood Glucose Monitoring System for quantitative glucose measurement using capillary whole blood and glucose oxidase methodology",
    "Indications for Use Summary": "Quantitative measurement of glucose in fresh capillary whole blood from the finger and forearm for home and healthcare professional use as an aid in monitoring diabetes control; not for diagnosis or neonatal use; includes audible result feature for users with low vision.",
    "fda_folder": "Clinical Chemistry"
}